145 related articles for article (PubMed ID: 38237965)
1. Pancreatic steatosis: Identification of yet another "new" modifiable high-risk factor for post-ERCP pancreatitis?
Weston BR
Gastrointest Endosc; 2024 Feb; 99(2):224-226. PubMed ID: 38237965
[No Abstract] [Full Text] [Related]
2. Postendoscopic retrograde cholangiopancreatography pancreatitis.
Shih HY; Hsu WH; Kuo CH
Kaohsiung J Med Sci; 2019 Apr; 35(4):195-201. PubMed ID: 30887733
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
Kawaguchi Y; Ogawa M; Omata F; Ito H; Shimosegawa T; Mine T
World J Gastroenterol; 2012 Apr; 18(14):1635-41. PubMed ID: 22529693
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of pancreatic duct stenting to prevent postendoscopic retrograde cholangiopancreatography pancreatitis after covered self-expandable metal stent deployment.
Toyonaga H; Hayashi T; Yamazaki H; Hama K; Iwano K; Nakamura R; Ando R; Shimizu T; Ishii T; Kin T; Takahashi K; Katanuma A
Dig Endosc; 2023 Mar; 35(3):369-376. PubMed ID: 36129765
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events: post-ERCP pancreatitis.
Rustagi T; Jamidar PA
Gastrointest Endosc Clin N Am; 2015 Jan; 25(1):107-21. PubMed ID: 25442962
[TBL] [Abstract][Full Text] [Related]
7. NSAIDs for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: ready for prime time?
Parsi MA
World J Gastroenterol; 2012 Aug; 18(30):3936-7. PubMed ID: 22912542
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.
Sofuni A; Maguchi H; Itoi T; Katanuma A; Hisai H; Niido T; Toyota M; Fujii T; Harada Y; Takada T
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1339-46. PubMed ID: 17981247
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.
Masci E; Mariani A; Curioni S; Testoni PA
Endoscopy; 2003 Oct; 35(10):830-4. PubMed ID: 14551860
[TBL] [Abstract][Full Text] [Related]
10. Prophecy about post-endoscopic retrograde cholangiopancreatography pancreatitis: from divination to science.
Moon SH; Kim MH
World J Gastroenterol; 2013 Feb; 19(5):631-7. PubMed ID: 23429236
[TBL] [Abstract][Full Text] [Related]
11. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis.
Akshintala VS; Sperna Weiland CJ; Bhullar FA; Kamal A; Kanthasamy K; Kuo A; Tomasetti C; Gurakar M; Drenth JPH; Yadav D; Elmunzer BJ; Reddy DN; Goenka MK; Kochhar R; Kalloo AN; Khashab MA; van Geenen EJM; Singh VK
Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):733-742. PubMed ID: 34214449
[TBL] [Abstract][Full Text] [Related]
12. Advances in pancreatobiliary endoscopy.
Coté GA; Sherman S
Curr Opin Gastroenterol; 2010 Sep; 26(5):429-35. PubMed ID: 20651588
[TBL] [Abstract][Full Text] [Related]
13. Pre- and post-procedure risk prediction models for post-endoscopic retrograde cholangiopancreatography pancreatitis.
Park CH; Park SW; Yang MJ; Moon SH; Park DH
Surg Endosc; 2022 Mar; 36(3):2052-2061. PubMed ID: 34231067
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for pancreatitis occurrence after gallstone treatment using endoscopic retrograde cholangiopancreatography.
Jiang F; Zhang J; Hu Z
Afr Health Sci; 2023 Jun; 23(2):231-238. PubMed ID: 38223651
[TBL] [Abstract][Full Text] [Related]
15. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
[TBL] [Abstract][Full Text] [Related]
16. Positive correlation between pancreatic volume and post-endoscopic retrograde cholangiopancreatography pancreatitis.
Maruyama H; Shiba M; Ishikawa-Kakiya Y; Kato K; Ominami M; Fukunaga S; Otani K; Hosomi S; Tanaka F; Kamata N; Taira K; Nagami Y; Yamagami H; Tanigawa T; Watanabe T; Yamamoto A; Kabata D; Shintani A; Fujiwara Y
J Gastroenterol Hepatol; 2020 May; 35(5):769-776. PubMed ID: 31618801
[TBL] [Abstract][Full Text] [Related]
17. Incidence, risk factors, and prevention of post-ERCP pancreatitis.
Cooper ST; Slivka A
Gastroenterol Clin North Am; 2007 Jun; 36(2):259-76, vii-viii. PubMed ID: 17533078
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis.
Tarnasky P; Cunningham J; Cotton P; Hoffman B; Palesch Y; Freeman J; Curry N; Hawes R
Endoscopy; 1997 May; 29(4):252-7. PubMed ID: 9255527
[TBL] [Abstract][Full Text] [Related]
19. [Endoscopic retrograde cholangiopancreatography: is it possible to effectively prevent ERCP-induced pancreatitis?].
Il'chenko AA
Eksp Klin Gastroenterol; 2008; (3):62-71. PubMed ID: 19145885
[No Abstract] [Full Text] [Related]
20. The role of endoscopic retrograde cholangiopancreatography in patients with pancreatic disease.
Buxbaum J
Gastroenterol Clin North Am; 2012 Mar; 41(1):23-45. PubMed ID: 22341248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
